Nomura Holdings’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-17,601
Closed -$2.22M – 1925
2024
Q2
$2.22M Buy
+17,601
New +$2.76M ﹤0.01% 916
2021
Q4
– Sell
-13,900
Closed -$3.91M – 2432
2021
Q3
$3.91M Buy
13,900
+1,100
+9% +$282K 0.01% 705
2021
Q2
$2.56M Sell
12,800
-7,569
-37% -$1.47M 0.01% 783
2021
Q1
$3.97M Buy
20,369
+13,168
+183% +$2.7M 0.01% 627
2020
Q4
$1.38M Buy
+7,201
New +$1.31M ﹤0.01% 943
2015
Q1
– Sell
-16,949
Closed -$338K – 2175
2014
Q4
$338K Buy
+16,949
New +$379K ﹤0.01% 1843

Other funds holding RGEN

Nomura Holdings's RGEN Position: Q3 2024 in Review

Nomura Holdings sold out of Repligen (RGEN) in Q3 2024, closing a stake of 17,601 shares — an estimated $2.22M sold.

Nomura Holdings first reported a position in RGEN in Q4 2014 and held it in 6 quarters. The position peaked at $3.97M in Q1 2021. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Nomura Holdings reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • Nomura Holdings sold 17,601 Repligen shares in Q3 2024, an estimated $2.22M.
  • Nomura Holdings first reported a position in Repligen in Q4 2014 and held it in 6 quarters.
  • Nomura Holdings's Repligen position peaked at $3.97M in Q1 2021.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.